Keywords
arrhythmia
How to Cite
Abstract
The article presents some aspects of structural-functional and electrophysiological cardiac remodeling, leading to the occurrence of cardiac arrhythmias in patients with arterial hypertension Awarded the role of genetic factors in the development of arrhythmias. However, cardiac haemodynamics that occur during an attack of arrhythmia may increase the pathological processes of cardiac remodeling in patients with arterial hypertension.References
Сиренко Ю.Н. Гипертоническая болезнь и артериальные гипертензии // Ю.Н. Сиренко. – Донецк: Изд. Заславский А.Ю., 2011. – 352 с.
Березин А.Е. Биологические маркеры кардиоваскулярных заболеваний: Руководство для врачей: В 3 ч. // А.Е. Березин. – К.: Морион. – 2014.
Oganov R.G. Strategies for the prevention of cardiovascular diseases in the Russian Federation / R.G. Oganov, G.J. Maslennikova // Clinical Medicine. – 2012. – Vol. 3. – P. 4–9.
Smakotina S.A. On the timing of medication use in patients with hypertension / S.A. Smakotina, O.L. Barbarash // Cardiovascular Therapy and Prevention. – 2008. –Vol. 7 (8). – P. 344–345.
Abbott R.D. Coronary heart disease and atrial fibrillation: The Framingham Study / R.D. Abbott, D.D. Savage, P.M. McNamara // Am. Heart J. – 1983. – Vol. 106. – P. 389–396.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation – executive summary / V. Fuster, L.E. Rydn, D.S. Cannom et al. Circulation. – 2006. – Vol. 114. – Р. 700–752.
Personalized management of atrial fibrillation: EHRA consensus statement / P. Kirchhof, G. Breithardt, Е. Aliot et al. // Europace. – 2013. – Vol. 15. – P. 1540–1556. – doi:10.1093/ europace/eut232
Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients / A. Milan, M.A. Caserta, A. Dematteis et al. // Hum. Hypertens. – 2009. – Vol. 23 (11). – P. 743–750.
Brugada R. Genetics of cardiovascular disease with emphasis on atrial fibrillation / R. Brugada, J. Brugada, R. Roberts // J. Interv. Card. Electrophysiol. – 1999. – Vol. 3. – Р. 7–13.
Джанашия П.Х. Экстрасистолия: клиническое значение, диагностика и лечение / П.Х. Джанашия, С.В. Шлык, Н.М. Шевченко // Лечащий врач. – 2007. – № 3. – C. 8–11.
Глезер М.Г. Современная концепция патогенеза постинфарктного ремоделирования сердца. Подходы к медикаментозной терапии / М.Г. Глезер, Е.И. Асташкин // Клиническая геронтология. – 2000. – Т. 6, № 1–2. – С. 33–43.
Cardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling / J.N. Cohn, R. Ferrari, N. Sharpe et al. // J. Coll. Cardiol. – 2000. – Vol. 35. – P. 569–582.
Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group) / C. Savoye, O. Equine, O. Tricot et al. // Amer. J. Cardiol. – 2006. – Vol. 98. – P. 1144–1149.
Yousef Z.R. Postinfarction left ventricular remodelling: where are the theories and trials leading us? / Z.R. Yousef, S.R. Redwood, M.S. Marber // Cardiovascular Drugs and Therapy. – 2000. – Vol. 14. – P. 243–252.
Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography / H.F.J. Mannaerts, J. A. Van der Heide, O. Kamp et al. // Eur. Heart J. – 2004. – Vol. 25. – P. 680–687.
Ferrari R. Oxidative stress during myocardial ischaemia and heart failure / R. Ferrari, L. Agnoletti, L. Comini // Eur. Heart J. – 1998. – Vol. 19. – P. 138–141.
Myocyte proliferation in end-stage cardiac failure in humans / J. Kajstura,
A. Leri, N. Finato et al. // Proc. Natl. Acad. Sci. – 1998. – Vol. 95. – P. 8801–8805.
Нечесова Т.А. Ремоделирование левого желудочка: патогенез и методы оценки / Т.А. Нечесова, И.Ю. Коробко, Н.И. Кузнецова // Медицинские новости. – 2008. – № 11. – С. 7–13.
Struthers A.D. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? / A.D. Struthers // Brit. Med. J. – 1994. – Vol. 308. – P. 1615–1619.
Goette A. Electrical remodeling in atrial fibrillation. Time course and mechanisms / A. Goette, C. Honeycutt, J. Langberg // Circulation. – 1996. – Vol. 94 (11). – P. 2968–2974.
Insights into myocardial microstructure during infarct healing and remodeling pathologists need not apply / C.M. Kramer, W.J. Rogers, T.M. Theobald et al. // Circulation. – 2006. – Vol. 94. – P. 660–666.
Bett G.C.L. Cardiac mechanosensitivity andstretch-activated ion channaels / G.C.L. Bett, F. Sachs // Trends. Cardiovasc. Med. – 1997. – Vol. 7. – P. 4–8.
Arrhythmias in patients with mechanical ventricular dysfunction and myocardial stretch: role of mechano-electric feedback / B. Sarubbi, V. Ducceschi, L. Santangelo, A. Iacono // Can. J. Cardiol. 1998. – Vol. 14 (2). – P. 245–252.
Hu H. Mechanically activated ion channels in the heart / H. Hu, F. Sachs // J. Mol. Cell. Cardiol. – 1997. – Vol. 29. – P. 1511–1523.
Sackin H. Mechanosensitive channels / Sackin H. // Annu. Rev. Physiol. – 1995. – Vol. 57. – P. 333–353.
Zeng T. Stretch-activated whole cell currents in cardiac myocytes / T. Zeng, G.C.L. Bett, F. Sachs // Am. J. Physiol. – 2000. – Vol. 278. – P. H548–H557.
Причинно-следственные связи возникновения фибрилляции предсердий у болных артериальной гипертензией / О.Н. Миллер, Т.А. Бахметьева, И.А. Гусева и др. // Вестник аритмологии. – 2006. – № 44. – С. 44–48
Hennersdorf M.G. Arterial hypertension and cardiac arrhythmias / M.G. Hennersdorf, B.E.Strauer // J. Hypertens. – 2001. – Vol. 19 (2). – P. 167–177.
Ca2+ influx through stretch-activated cation channels activated maxi K+ channels in porcine endocardial endothelium / J. Hoyer, A. Distler, W. Haase et al. // PNAS. – 1994. – Vol. 91. – P. 2367–2371.
Machanelectric feedback in right atrium after ventricular in arction in rats / A. Kamkin, I. Kiseleva, K.D. Wagner et al. // J. Mol. Cell. Cardiol. – 2000. – Vol. 3. – P. 465–477.
Stretch-activated and background non-selective cation channels in rat atrial myocytes / Y.H. Zhang, J.B. Youm, H.K. Sung et al. // J. Physiol. (London). – 2000. – Vol. 253. – P. 607–619.
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study / A.M. Кhan, S.A. Lubitz, L.M. Sullivan et al. // Circulation. – 2013. – Vol. 127 (1). – P. 33–38.
Sparks E. Heritable cardiovascular disease in women / E. Sparks, L. Fraizier // J. Obstet. Gynecol. Neonatal Nurs. – 2002. – Vol. 31. – P. 217–228.
C825T polymorphism of the protein beta-3 subunit gene and atrial fibrillation: association of the gehotype with a reduced risk for atrial fibrillation / J. Schreieck, S. Dostal, von N. Beckerath et al. // Heart. – 2004. – Vol. 90. – P. 1310–1314.
Atrial fibrillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue / L.P. Lai, C.C. Tsai, M.J. Su et al. // Chest. – 2003. – Vol. 123. – Р. 539–544.
Renin-angiotensin gene polymorphism and atrial fibrillation / C. Tsai, L. Lai, F. Chang et al. // Clin. Sci. – 2004. – Vol. 106. – P. 653–659.
Целуйко В.И. Роль интерстициального фиброза как предиктора возникновения фибрилляции предсердий / В.И. Целуйко, С.Ю. Дмитриев // Медицина неотложных состояний. – 2007. – № 3 (10). – P. 124–126.
Преображенский Д.В. Медикаментозное лечение мерцания предсердий / Д.В. Преображенский, Б.А. Сидоренко. – Москва, 2003. – С. 38–52.
Lopez-Candales A. Is the presence of interatrial septal hypertrophy a marker for atrial fibrillation in the elderly? / А. Lopez-Candales // Am. J. Geriatr. Cardiol. – 2002. – Vol. 11 (6). – P. 399–403.